首页> 外国专利> METHOD TO ASSESS PROGNOSIS AND TO PREDICT THERAPEUTIC SUCCESS IN CANCER BY DETERMINING HORMONE RECEPTOR EXPRESSION LEVELS

METHOD TO ASSESS PROGNOSIS AND TO PREDICT THERAPEUTIC SUCCESS IN CANCER BY DETERMINING HORMONE RECEPTOR EXPRESSION LEVELS

机译:通过测定激素受体表达水平评估癌症的预后和预测治疗成功的方法

摘要

The present invention is related to a method of classifying a sample of a patient who suffers from or being at risk of developing cancer, said method comprising the steps of determining in said sample from said patient, on a non protein basis, the expression level of at least one gene encoding for a hormone receptor selected from the group comprising estrogen receptor, progesterone receptor and/or androgen receptor in said sample; comparing the one or more expression level(s) determined with one or more expression level(s) of one or more reference genes, and classifying the sample of said patient from the outcome of the comparison into one of at least two classifications.
机译:本发明涉及一种对患有癌症或有患癌症风险的患者样品进行分类的方法,所述方法包括以下步骤:在非蛋白质基础上确定来自所述患者的所述样品的表达水平。在所述样品中,至少一种编码激素受体的基因选自包括雌激素受体,孕激素受体和/或雄激素受体的组;将确定的一种或多种表达水平与一种或多种参考基因的一种或多种表达水平进行比较,并根据比较结果将所述患者的样品分类为至少两种分类之一。

著录项

  • 公开/公告号US2016355889A1

    专利类型

  • 公开/公告日2016-12-08

    原文格式PDF

  • 申请/专利权人 RALPH WIRTZ;

    申请/专利号US201615178660

  • 发明设计人 RALPH WIRTZ;

    申请日2016-06-10

  • 分类号C12Q1/68;

  • 国家 US

  • 入库时间 2022-08-21 13:44:18

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号